Category: Biomarker

November 30, 2022

The company also announced dosing of the first patient in its Phase 1 clinical trial of NTX1088, Nectin’s first-in-class PVR blocker, in cancer patients with locally advanced and metastatic solid tumors. NTX1088 is a first-in-class high affinity monoclonal antibody directed […]

November 23, 2022

The US Food and Drug Administration (FDA) has granted emergency use authorisation (EUA) for Lucira Health’s COVID-19 & Flu Test for use in point-of-care settings. The nucleic acid amplification test (NAAT)/molecular test has been developed for the simultaneous rapid in […]

November 21, 2022

Johns Hopkins University School of Medicine in Maryland, US, has announced that a new artificial intelligence (AI)-based blood testing technology was found to detect more than 80% of liver cancers in a study. The new blood test, dubbed DNA evaluation […]

November 18, 2022

Approximately 80% of reproductive-aged women develop uterine fibroids —non-cancerous tumors that grow in the uterus — yet it’s often unclear what causes them. Scientists have long suspected that genetics play a role, as do hormones, diet and major life stressors. […]

November 16, 2022

Inflammatory skin conditions such as atopic dermatitis, psoriasis, vitiligo, hidradenitis suppurativa and others impact a significant portion of the U.S. population. In fact, nearly half of all visits to primary care physicians include some level of dermatological indication. Many of […]

November 14, 2022

Neonatal monitoring allows healthcare providers to track and screen newborns for basic functions, including monitoring temperature, oxygen saturation (SpO₂), blood pressure, heart rate and respiration rate. Higher-end monitors incorporate accessories such as resuscitation systems, intravenous lines for feeding/blood/medication, ventilation, and […]

November 14, 2022

November is Lung Cancer Awareness Month, a time aimed at raising awareness for the world’s leading cause of cancerous deaths. According to the International Agency for Research on Cancer, the estimated annual mortality due to lung cancer is projected to […]

November 7, 2022

AMPEL BioSolutions has unveiled a new genetic precision medicine test that can predict heart disease at an early stage in women with lupus. The new CardioGENE lab test also provides decision support for prophylactic therapies. It uses blood samples to […]

November 3, 2022

Dutch company Enzyre has raised $11.85m (€12m) in a Series A financing round to accelerate the development of its ambulant diagnostic technology platform for haemophilia patients. Led by new investor Oost NL, the financing round also saw participation from Demcon […]

November 2, 2022

Proscia is a software company that is accelerating pathology’s digital transformation to change the way we understand diseases like cancer. Its Concentriq digital pathology platform and powerful AI applications are advancing the 150-year-old standard of research and diagnosis towards a […]

October 28, 2022

Researchers at Qatar University (Qu) and University of Warwick (UoW) in the UK have developed a new blood test to diagnose early-stage osteoarthritis. The new test quantifies modified amino acids that are released into the blood from proteins in the […]

October 25, 2022

Roche Diagnostics has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its cobas SARS-CoV-2 Qualitative PCR test. The new real-time RT-PCR test has been designed for the qualitative detection of nucleic acids from SARS-CoV-2 in nasal […]

October 17, 2022

Millions of people get breast biopsies every year, and yet the ins and outs of the procedure are seldom openly discussed. Breast biopsies help doctors diagnose different types of breast lumps and lesions. If your radiologist can’t immediately rule out […]

October 14, 2022

Breast cancer is a condition that’s usually associated with those who are women. The disease occurs in more than 280,000 women in the United States each year and is the topic of study at many research hospitals. But it’s an […]

October 13, 2022

Roche is set to introduce its three next-generation SARS-CoV-2 rapid antigen tests (‘2.0’) for self-test and professional use in countries that accept the CE Mark. The tests include the SARS-CoV-2 Rapid Antigen Test 2.0, the SARS-CoV-2 Rapid Antigen Test 2.0 […]

October 5, 2022

Every year, about 264,000 women in the United States are diagnosed with breast cancer. The enormity of this number underscores the importance of understanding your personal risk, abiding by guidelines for screenings and being otherwise on alert for any early […]

October 3, 2022

In April 2022, Clea Shearer ― co-founder of the popular organization company The Home Edit ― announced that she had breast cancer. The diagnosis came after she discovered a lump in her breast and called multiple doctors to go in […]

September 29, 2022

A research team from the University of Southern California (USC) has found that a blood test can detect nano-sized signs of early-stage breast cancer. Conducted in a small group of patients, the study showed that the liquid biopsy can determine […]

September 28, 2022

With rising cancer cases and thousands of people dying from the disease every year, oncology has incorporated precision and personalised medicine more quickly than other fields of medicine. Precision and personalised medicine is a customised medicine that allows treatment to […]

September 22, 2022

Non-invasive, blood-based liquid biopsy tests have long been touted as the future for cancer diagnostics, but studies presented at the recent European Society for Medical Oncology (ESMO) Congress 2022, highlight the challenges remaining before they can reach routine clinical practice. […]